David C. Dreyer, SVP / Chief Financial Officer at BIOLASE, INC (BIOL), bought 5,000 shares at $1.37 ($7K) on 2015-09-22, disclosed to the SEC on 2015-09-24.
Open-market purchase of $7k BIOL by SVP / Chief Financial Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| Filing → |
| INFU | SELL | 2018-06-26 | $156K | — | Filing → |
| INFU | SELL | 2018-06-15 | $655K | — | Filing → |
| BIOL | BUY | 2015-11-12 | $25K | — | Filing → |